Founded in 2019, Auxi Therapeutics Sdn Bhd

is a company specializing in providing variety of T-cell-based immunotherapies for cancer treatment. With best-in-class capacity and capacity in both sales and marketing, AUXI support scientific endeavors through ofering high-quality cancer treatment and services. As a fast-growing enterprise, the diverse portfolio of AUXI encompasses extensive services in individualized T-cell-based immunotherapies treatment and engineering together with iCARTab BioMed, one stop solution for healthcare services as well as medical travel tourism. With the mission of “Real Hope, Treat More” that aim to create a hope to cure and treat more the cancer patients, AUXI has strived to remain a real afordable & ease of accessible treatment for all cancer patients.